Experimental study reveals efficient chemoenzymatic synthesis of glycophorin A tetrasaccharide analogues, indicating potential utility for protein-binding and mass spectrometry libraries.
A large‐scale chemoenzymatic methodology has been developed to prepare a natural and substituted analogues of the Glycophorin A tetrasaccharide, in which the α‐2,3‐sialic acid is modified at either C5 or C9 either as F, OMe, CH 3 , glycolyl or N 3 . The strategy involved a chemical synthesis of a Gal‐β‐1,3‐GalNAc disaccharide in which the galactose remains acetylated to first enable selective α‐2,6‐sialylation using a one‐pot aldolase‐NmCSS‐Pd2,6‐ST enzyme system. Finally, C5 or C9 modifed α‐2,3 sialosides were placed at the galactoside moiety using C2 or C6 modified MaNAc derivatives catalyzed by aldolase NmCSS‐Pd2,3‐ST enzyme combination. The synthesised molecules can be useful in binding studies with a protein of interest or as an entry point to establish a library of analytical samples for mass‐spectrometric studies.
No takes yet. Share an insight, caveat, or question.
Gagarinov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: